Some may feel numbness or tingling in their hands and feet, or have trouble walking
Semaglutide 2.4mg (GLP-1 Agonist): Proven GLP-1 effects (appetite suppression, gastric emptying) Already FDA-approved as Wegovy Established safety profile Cagrilintide 2.4mg (Amylin Analog): Mimics amylin, a hormone co-secreted with insulin Slows gastric emptying through different pathway than GLP-1 Reduces appetite through hindbrain (not hypothalamus) Improves postprandial glucose The Advantage: Leverages proven semaglutide efficacy and safety, adds complementary amylin effects
This is the use case where AOD-9604 has the most appeal but potentially the least clinical data to support it
Visible effects on muscle, tendon, and joint repair often appear over several weeks
$249 Vitamin D Shot IM Injection Are you familiar with the "sunshine" nutrient
Always, always speak with a qualified medical professional before considering any experimental compound